Product Images Lidothol
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Lidothol NDC 80425-0516 by Advanced Rx Of Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Lidothol Gel 99g - Lidothol Gel 80425 0516 01
This is a description of a package labeled as "LIDOTHOL GEL" with a quantity of 99 grams. The NDC numbers are provided as 80425-0516-01 (source NDC: 83881-0455-35). It indicates the lot number as "XXXXXX" with an expiration date of December 31, 2026. The text also mentions "anoo geL g9" with a barcode serial number of "000000372720". Additional details state "o on teprarat e."*
Package Insert (1) - Lidothol Package Insert 102424 01 (1)
.jpg "Lidothol Package Insert 102424-01 (1).jpg")
This text provides detailed information about the dosage, administration, handling, disposal, adverse reactions, and clinical pharmacology of Lidothol™, a gel containing 4.5% Lidocaine HCL and 5% Menthol used for topical pain relief. It includes instructions on application, potential side effects, warnings about absorption when used with other local anesthetic products, safety precautions, overdosage management, and a list of ingredients. The description also outlines the pharmacodynamics and pharmacokinetics of Lidocaine, emphasizing the absorption levels from the gel applied to the skin. Additionally, it mentions the potential systemic side effects and adverse reactions associated with the product, providing a comprehensive overview for healthcare professionals and consumers.*
Package Insert (2) - Lidothol Package Insert 102424 02 (1)
.jpg "Lidothol Package Insert 102424-02 (1).jpg")
Lidothol™ is a topical medication indicated for relieving pain associated with various conditions such as arthritis, backache, cramps, and strains when applied to intact skin. It contains lidocaine, which is distributed in the body and primarily bound to plasma proteins. The drug is metabolized in the skin and excreted by the kidneys. However, caution is advised in patients with certain conditions like hepatic disease or sensitivity to local anesthetics. There are warnings regarding the risk of methemoglobinemia, excessive dosing, and precautions related to allergic reactions, application on non-intact skin, use with external heat sources, eye exposure, and potential drug interactions. It is essential to follow instructions carefully to avoid adverse effects and seek medical attention if needed.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
